3.95
Genelux Corp stock is traded at $3.95, with a volume of 294.19K.
It is up +8.22% in the last 24 hours and up +23.82% over the past month.
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
See More
Previous Close:
$3.65
Open:
$3.67
24h Volume:
294.19K
Relative Volume:
2.23
Market Cap:
$149.21M
Revenue:
-
Net Income/Loss:
$-27.66M
P/E Ratio:
-4.1579
EPS:
-0.95
Net Cash Flow:
$-24.36M
1W Performance:
+17.21%
1M Performance:
+23.82%
6M Performance:
+4.50%
1Y Performance:
+47.94%
Genelux Corp Stock (GNLX) Company Profile
Name
Genelux Corp
Sector
Industry
Phone
805-267-9889
Address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Compare GNLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GNLX
Genelux Corp
|
3.95 | 137.87M | 0 | -27.66M | -24.36M | -0.95 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-29-24 | Initiated | Guggenheim | Buy |
Aug-28-24 | Initiated | ROTH MKM | Buy |
Nov-27-23 | Initiated | H.C. Wainwright | Buy |
Sep-12-23 | Initiated | Maxim Group | Buy |
Feb-15-23 | Initiated | The Benchmark Company | Speculative Buy |
Genelux Corp Stock (GNLX) Latest News
Volatility clustering patterns for Genelux CorporationGold Moves & Capital Efficient Trading Techniques - Newser
Full technical analysis of Genelux Corporation stockQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Detecting price anomalies in Genelux Corporation with AI2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Alyeska Investment Group L.P. Invests $770,000 in Genelux Corporation $GNLX - MarketBeat
Is Genelux Corporation stock poised for growthShare Buyback & Community Consensus Trade Alerts - Newser
What does recent volatility data suggest for Genelux CorporationWeekly Gains Summary & Smart Money Movement Alerts - Newser
Will breakout in Genelux Corporation lead to full recovery2025 Macro Impact & Weekly Momentum Stock Picks - Newser
Technical signs of recovery in Genelux Corporation2025 Bull vs Bear & Precise Swing Trade Entry Alerts - Newser
Genelux Corporation stock trendline breakdownJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - Newser
What technical models suggest about Genelux Corporation’s comeback2025 Support & Resistance & Safe Swing Trade Setups - Newser
Institutional scanner results for Genelux CorporationEarnings Overview Summary & Short-Term Swing Trade Alerts - Newser
OMERS ADMINISTRATION Corp Invests $215,000 in Genelux Corporation $GNLX - MarketBeat
Should you hold or exit Genelux Corporation nowWeekly Stock Recap & Safe Investment Capital Preservation Plans - Newser
Does Genelux Corporation stock reflect fundamentalsWeekly Earnings Recap & High Accuracy Buy Signal Tips - Lancaster City Council
Using economic indicators to assess Genelux Corporation potentialDividend Hike & Reliable Trade Execution Plans - Newser
Is Genelux Corporation stock entering bullish territoryJuly 2025 Outlook & Long-Term Investment Growth Plans - Newser
technical analysis overview for genelux corporation stockJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser
What institutional flow reveals about Genelux Corporation2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Pattern recognition hints at Genelux Corporation upsidePortfolio Performance Summary & Short-Term Swing Trade Alerts - Newser
Why Genelux Corporation is moving todayOil Prices & Risk Managed Investment Signals - Newser
Is a relief rally coming for Genelux Corporation holdersJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Is Genelux Corporation showing signs of accumulation2025 Market WrapUp & Safe Capital Allocation Plans - Newser
Is Genelux Corporation still worth holding after the dipTake Profit & Fast Exit/Entry Strategy Plans - Newser
Does Genelux Corporation show high probability of rebound2025 Price Targets & Safe Entry Point Identification - Newser
Is Genelux Corporation forming a bullish divergence2025 Institutional Moves & Capital Protection Trade Alerts - خودرو بانک
Genelux Corporation stock daily chart insightsMarket Activity Summary & Breakout Confirmation Alerts - Newser
Charles Schwab Investment Management Inc. Purchases New Shares in Genelux Corporation $GNLX - Defense World
Is Genelux Corporation a top pick in the sectorQuarterly Growth Report & Growth Focused Investment Plans - خودرو بانک
Genelux Corp. Lowers Stock Option Exercise Prices - MSN
S P Trends: What are the risks of holding Genelux CorporationQuarterly Trade Review & AI Enhanced Trading Alerts - خودرو بانک
What is Genelux Corporation s revenue forecastWeekly Profit Summary & Safe Capital Growth Plans - خودرو بانک
Using flow based indicators on Genelux CorporationJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Can a trend reversal in Genelux Corporation lead to recoveryJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
Tools to monitor Genelux Corporation recovery probabilityTrend Reversal & Expert Approved Momentum Ideas - Newser
Immuno-Oncology Pioneer Genelux Leadership Team Featured at H.C. Wainwright Global Investment Conference - Stock Titan
How to interpret RSI for Genelux Corporation stockJuly 2025 Setups & Verified Momentum Stock Watchlist - Newser
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference - Yahoo Finance
Is Gores Holdings IX Inc. Equity Warrant exposed to political riskPortfolio Gains Report & Free Weekly Watchlist of Top Performers - خودرو بانک
Oncolytic Virus Cancer Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail
Leading vs lagging indicators on Genelux Corporation performancePortfolio Profit Report & Growth Oriented Trade Recommendations - Newser
Genelux Corporation Stock Approaches Key Moving Average2025 Big Picture & Daily Price Action Insights - beatles.ru
Technical analysis overview for Genelux Corporation stockJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Using Bollinger Bands to evaluate Genelux CorporationWeekly Stock Summary & Verified Entry Point Signals - Newser
Genelux Corporation stock prediction for this week2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-08-30 23:56:19 - Newser
Genelux Corp Stock (GNLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):